CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow -2.4% ·
net new positions +20.0%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.53M | +16.1% | $50.22M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 860.93K | -29.4% | $17.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 559.77K | +331.2% | $11.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 301.65K | New | $6.00M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 159.31K | New | $3.17M | 0.0% | New | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 91.77K | New | $1.82M | 0.0% | New | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 86.80K | -17.8% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 59.58K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 59.58K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 59.58K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 59.58K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 36.14K | +7.2% | $718,483 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 25.24K | -95.7% | $501,731 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $6.00M | 0.0% |
| Two Sigma Investments | $3.17M | 0.0% |
| Norges Bank | $1.82M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
Exited
| Point72 Asset Management | $9.58M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 378 holders, 103.75M shares, $2.50B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.